載入...
The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice
Hepatitis B virus (HBV) infection is a major health burden worldwide with 240 million chronically infected individuals. Nucleos(t)ide analogs and interferons are the current standards of care due to their suppression of HBV replication, but the treatments rarely eradicate HBV from individuals. Simil...
Na minha lista:
| 發表在: | PLoS One |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Public Library of Science
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6557616/ https://ncbi.nlm.nih.gov/pubmed/31181107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0217433 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|